Nearly half of the world’s population risks catching malaria.
The need to step up and take the fight to the disease has never been more pressing to the vulnerable, primarily in sub-Saharan Africa.
By the end of October last year, more than 16 000 cases resulted in 110 deaths just in the southern Africa region. This is more people than the 7 600 average of the 10-year period between 2007 and 2016.
Insecticide brand Bayer is rising to this challenge with the launch its new indoor-residual spray, Fludora Fusion, a new weapon in Africa’s fight against malaria.
Dr Jacqueline Applegate, the head of environmental science at Bayer, said: “Insecticide resistance remains a huge challenge in the battle against malaria because it reduces the amount of safe but effective insecticides every year. Research can only produce so many new effective but safe replacements after many years of testing.”
Every year, new mosquitoes are born that are more or less resistant to an existing toxin and because they are resistant, they pass the genetic resistance to their offspring.
“Eventually, the only mosquitoes in an area are the toxin-resistant survivors of that one mosquito.”
“What makes insecticide resistant mosquitoes worse is the evidence that existing malaria zones are expanding into previously malaria-free areas in South Africa and other countries.”
Trials in 16 African countries show that Fludora Fusion is not only effective against more than a dozen insecticide resistant strains of mosquitoes, but that it remains effective for up to 12 months after application.